

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 25mg | 360 pills | €1.02 | €525.11 €367.58 Best Price | |
| 25mg | 180 pills | €1.14 | €291.72 €204.20 | |
| 25mg | 120 pills | €1.25 | €214.62 €150.23 | |
| 25mg | 90 pills | €1.40 | €179.19 €125.43 | |
| 25mg | 60 pills | €1.56 | €133.35 €93.34 | |
| 25mg | 30 pills | €1.94 | €83.33 €58.33 | |
| 50mg | 180 pills | €1.71 | €439.67 €307.77 | |
| 50mg | 120 pills | €1.82 | €312.56 €218.79 | |
| 50mg | 90 pills | €1.97 | €254.21 €177.95 | |
| 50mg | 60 pills | €2.22 | €189.61 €132.73 | |
| 50mg | 30 pills | €2.73 | €116.67 €81.67 | |
| 100mg | 180 pills | €1.95 | €502.19 €351.53 | |
| 100mg | 120 pills | €2.07 | €354.23 €247.96 | |
| 100mg | 90 pills | €2.38 | €306.30 €214.41 | |
| 100mg | 60 pills | €2.86 | €245.87 €172.11 | |
| 100mg | 30 pills | €3.82 | €164.60 €115.22 | |
| 200mg | 120 pills | €4.19 | €716.82 €501.78 | |
| 200mg | 90 pills | €4.45 | €573.04 €401.13 | |
| 200mg | 60 pills | €5.09 | €435.50 €304.85 | |
| 200mg | 30 pills | €6.49 | €279.21 €195.45 | |
| 300mg | 90 pills | €5.97 | €766.84 €536.78 Popular | |
| 300mg | 60 pills | €6.42 | €550.11 €385.08 | |
| 300mg | 30 pills | €8.07 | €345.90 €242.13 |
Disclaimer: This information is for adults in Ireland and is not a substitute for professional medical advice. Always consult a pharmacist or doctor for personal guidance.
Could mood instability and sleep disturbances be limiting daily life and functioning? Seroquel is the brand name for quetiapine, an atypical antipsychotic medication used to help manage certain mental health conditions. The medicine acts on several neurotransmitter systems in the brain to help stabilise mood, thinking, and behavior.
Quetiapine is available in tablet form with different release profiles. The immediate-release form is often taken in divided doses, while an extended-release form may be taken once daily. The exact form and dose depend on the condition being treated, the patient’s response, and other medicines being used. In Ireland, access may require a prescription depending on local rules.
Quetiapine is designed to help reduce symptoms such as mood swings, intrusive thoughts, agitation, and sleep disturbance associated with certain psychiatric conditions. It is not a general sleep aid and should be used only as prescribed for approved indications. The medication works by modulating signals in brain circuits that regulate mood and perception.
Clinical use requires careful consideration of medical history, other medicines, and potential side effects. The medication should be used under supervision of a clinician who can monitor response and tolerability, adjust dosing, and provide safety guidance. The information provided here is intended to support discussion with a pharmacist or clinician and should not replace professional advice.
Quetiapine tablets should be swallowed whole with water. Do not break, crush, or chew extended-release tablets unless specifically instructed by a clinician. Medication handling should follow local guidance and the product packaging. Any changes in therapy should be discussed with a prescriber or pharmacist to ensure continued safety and efficacy.
Quetiapine is prescribed for certain mental health conditions in adults and, in some cases, younger people under specialist supervision. The primary indications include schizophrenia and bipolar disorder, which encompasses episodes of mania and depression. In some circumstances, it may be used as an add-on treatment to antidepressants in major depressive disorder, according to clinical judgment and local guidelines.
The prescriber will consider the person’s full medical history, current medications, and any prior responses to treatment when determining suitability. Information about possible drug interactions, organ function (for example, liver function), and concomitant conditions is reviewed to minimise risk. The Irish healthcare context involves careful assessment by a clinician, with monitoring planned to track effectiveness and tolerability.
Adolescents and younger adults may receive quetiapine in specialised care settings where approved indications allow. The decision to treat younger patients is guided by evidence, clinical need, and safety considerations. If there is uncertainty about suitability, a pharmacist or clinician can discuss alternatives or additional monitoring requirements.
Quetiapine is generally not the first-line treatment for all psychiatric conditions and is selected when other options have not provided sufficient benefit or when symptom profiles suggest a potential advantage from this mechanism of action. The decision to start therapy is made following a careful discussion of risks and benefits with the patient or their carers, taking into account patient preferences and treatment goals.
Initiation of therapy is approached with caution, aiming to balance symptom control with tolerability. The plan is tailored to the individual by the clinician. The following steps outline the typical process, but local practice and individual circumstances may differ.
Initial preparation involves confirming the exact formulation, strength, and dosing schedule with the prescriber. A review of current medications and any known allergies is conducted, and information about other health conditions is gathered. The goal is to minimise interactions and plan appropriate monitoring.
A titration plan is often employed to mitigate side effects while achieving symptom control. Gradual dose increases allow the body to adapt and enable assessment of benefit versus adverse effects. Medication seen as beneficial may be continued with ongoing monitoring, while adjustments may be needed if tolerability is limited.
Follow-up appointments are arranged to assess response, manage any adverse effects, and consider stepwise dose adjustments. Open communication with the prescriber and pharmacist is encouraged to report changes in mood, sleep, or daily functioning. If any new medicines are started, their potential interactions will be reviewed and managed accordingly.
In all cases, strict adherence to the prescribed plan is advised. Do not modify the dose or discontinue treatment without professional input. Pharmacists can assist with education on administration, timing, and what to do if a dose is missed or if concerns arise during the course of therapy.
The first step involves verifying the exact medication prescribed (Seroquel or quetiapine), including strength and release type. A clinician will review health history, including liver function, kidney function, and any psychiatric or medical conditions that could affect treatment. The patient should disclose all medicines, including over-the-counter products and supplements, to avoid interactions.
Allergies should be clearly stated, and any prior adverse reactions to antipsychotic medicines should be reported. This helps ensure that the chosen regimen is appropriate and safe. Documentation of pregnancy status or plans, if applicable, is also important for safety considerations.
If there is any uncertainty about the medication form or dosing plan, it is prudent to consult with a pharmacist or prescriber before starting. Access to up-to-date product information or leaflets can aid understanding of how to use the medicine correctly. Local guidelines may influence initial decisions and monitoring requirements.
Following confirmation, a practical plan for administration is prepared. The plan includes instructions on timing, whether to take with food, and the anticipated pace of dose titration. Information about potential interactions with other medications is provided to reduce the risk of adverse effects or reduced efficacy.
Preparation involves arranging considerations for potential side effects and the expected time frame for noticing benefits. The clinician may discuss possible sedative effects and how these could impact daily activities, especially in the initial days. Information on safety measures, such as avoiding activities that require full alertness if drowsiness occurs, is provided.
Baseline monitoring plans are established. This may include weight, blood pressure, mood assessment, sleep patterns, and certain laboratory tests if indicated by the clinical picture. The purpose is to establish a reference point and to detect any emerging concerns early during treatment.
Patients are advised on what to do if a dose is missed and when to contact the prescriber. Simple, practical guidelines help maintain continuity of treatment and reduce unnecessary interruptions. The role of the pharmacist in reinforcing these guidelines is highlighted to support safe use.
Education materials and support resources are shared to aid understanding of the treatment. This may include information about common side effects, how to manage them, and when to seek assistance. The emphasis remains on patient safety and informed decision-making throughout the course of therapy.
A typical initiation plan involves starting at a low dose and gradually increasing to a target range over days to weeks, as tolerated. The pace of titration is tailored to the individual and the clinical response. The aim is to achieve symptom control while minimising adverse effects such as sleepiness or dizziness.
Decisions about whether to take medication in the morning or at night are made based on expected effects and daily routine. For many patients, a nighttime dose can help with sleep-related symptoms and reduce daytime sedation. Any adjustments to timing should be guided by the prescriber and pharmacist, with careful attention paid to how these changes affect daily functioning.
During titration, the patient is encouraged to report tolerability issues, including excessive sleepiness, dizziness on standing, or unexplained mood changes. The healthcare team can respond by modifying the dosing plan or adding supportive measures. Regular engagement with the care team supports a safe and effective transition to the maintenance dose.
Comprehensive documentation of responses and side effects supports ongoing treatment decisions. If a discontinuation or a major change in therapy is considered, a structured plan is provided to avoid withdrawal symptoms or abrupt deterioration in symptoms. The process emphasises safety, continuity of care, and patient education.
Follow-up visits assess treatment response, tolerability, and adherence. Checks may include symptom scales, sleep quality assessments, and general well-being. If responses are insufficient or adverse effects are unacceptable, adjustments are discussed and implemented as appropriate.
The care team may coordinate with other professionals, such as a psychiatrist or psychologist, to optimise overall care. Monitoring plans are adjusted to reflect changes in health status, other medications, or new clinical concerns. Ongoing communication is encouraged to ensure the therapy remains appropriate and safe.
Education continues at each step, with emphasis on recognising warning signs that require urgent medical attention. Information about emergency contacts, when to seek urgent help, and how to reach a clinician outside normal hours is provided where available. Patient safety remains paramount throughout the treatment course.
In summary, initiation and titration are individualized processes guided by clinical response and tolerability. The overall aim is to achieve meaningful symptom improvement with the fewest possible adverse effects, under careful supervision and regular review.
How quetiapine is taken—including timing, whether with food, and what to do if a dose is missed—depends on the formulation and the prescriber’s plan. The instructions provided by the clinician should be followed precisely. The information here offers general guidance and should not replace the product leaflet or professional advice.
Timing is selected to balance symptom control with tolerability. For many patients, taking the medicine at night can help manage drowsiness and sedation during daytime activities. If an extended-release form is prescribed, a single daily dose may be recommended, with timing aligned to daily routines and monitoring outcomes.
With or without food varies by formulation. Some immediate-release forms permit taking with or without food, while extended-release forms may have specific timing recommendations. The exact guidance will be provided by the prescriber and pharmacist. Any deviations should be discussed before making changes.
Missed doses should be managed according to the plan discussed with the clinician. In many cases, if a dose is missed, it can be taken as soon as remembered on the same day, provided it does not lead to an unintended double dose. If the next dose is approaching, skip the missed dose and resume the regular schedule. Do not double-dose to catch up unless advised by a clinician.
Daily usage should be maintained consistently to support stable drug levels and symptom control. If routine disruptions occur—such as travel or changes in work hours—discuss with the prescriber or pharmacist to adjust the schedule safely. Any questions about timing, meals, or dose adjustments can be addressed in consultation with the healthcare team.
Some formulations allow taking with or without food, while others may have specific instructions. The exact guidance depends on the product form prescribed. If there is any doubt, check the patient information leaflet or contact a pharmacist for clarification. Consistency in how food is used with the dose helps maintain predictable blood levels.
The general principle is that a missed dose should not be doubled or replaced with a larger dose without professional input. If a dose is forgotten, it may be taken as soon as remembered if there is a reasonable time before the next dose. If the next dose is approaching, skip the missed dose and resume the regular schedule. Guidance may vary by individual plan, so consult the pharmacist or prescriber if unsure.
Changes in routine can influence the timing of doses. In such cases, the prescriber or pharmacist should be contacted to determine a safe and practical plan. Some adjustments may be possible without compromising safety or efficacy, but they should be made under professional guidance rather than independently.
Initial responses often take time, and symptom improvement may be gradual. Sleep quality, daytime energy, and mood stability can change at different rates for different individuals. It is common for noticeable progress to occur over several days to weeks, not immediately.
Adverse effects are possible during the early phase of treatment. Drowsiness, dizziness on standing, dry mouth, and increased appetite or weight changes may occur. The clinician may adjust the dose, switch timing, or offer supportive measures to improve tolerability while maintaining efficacy.
Metabolic effects, including changes in blood sugar, cholesterol, and weight, can emerge with antipsychotic medicines. Regular monitoring as advised by the prescriber helps identify and manage these potential concerns. If significant symptoms arise, timely reporting supports safe management.
Interactions with other medicines or substances can modify how quetiapine acts. Alcohol, sedatives, or other central nervous system depressants may enhance sedation or coordination difficulties. It is important to discuss all substances used, including herbal products or over-the-counter medicines, with a clinician or pharmacist.
Not all patients experience the same trajectory. If improvement is slower than expected or if new symptoms appear, contact the prescriber to review the plan. Adjustments to dose, formulation, or additional therapies may be considered to optimise outcomes while preserving safety.
Safety considerations are essential during treatment with Seroquel. The following points highlight key cautions and when urgent medical advice is warranted. Detailed information about interactions and contraindications is available in the official product leaflet and from the pharmacist.
Contraindications include known hypersensitivity to quetiapine or any component of the product. Severe liver impairment or other conditions that affect metabolism may influence dosing and safety. Consult a clinician before starting if such conditions are present. In all cases, use is guided by clinical need and risk assessment.
Serious adverse effects are uncommon but require prompt attention. Seek urgent medical help if signs such as persistent fever, severe muscle stiffness, confusion, or changes in heart rate or rhythm occur. These symptoms may indicate a rare but potentially serious reaction that requires evaluation by a healthcare professional.
Common side effects include drowsiness, dizziness, dry mouth, constipation, and weight changes. Some patients may experience changes in blood pressure or mood, particularly during dose adjustments. The risk and severity vary between individuals and should be discussed with the clinician and pharmacist during follow-up appointments.
Older adults, particularly those with dementia-related conditions, are at higher risk for certain adverse outcomes with antipsychotic medicines. The decision to use quetiapine in these populations is made with special consideration and increased monitoring. Any concerns should be raised with the care team promptly.
Proper storage helps maintain the quality and effectiveness of Seroquel. The tablets should be kept in their original packaging, in a cool, dry place away from direct light. Keep out of reach of children and away from pets. Do not transfer tablets to other containers unless instructed by a pharmacist.
Extended-release and immediate-release forms may have different handling requirements. Do not crush or split extended-release tablets unless explicitly advised by a clinician. For safety, store away from moisture and heat, avoiding bathroom storage if possible.
Disposal should follow local guidelines. Do not discard medicines in household waste orFlush them down the toilet unless advised. Some medicines can be returned to a pharmacy for safe disposal. Check with the local pharmacist for disposal options and regulatory guidance to protect people and the environment.
If the supply is interrupted or expiry is reached, consult a pharmacist for disposal instructions and options for obtaining a replacement. Properly managed storage and disposal contribute to safe use and prevent accidental exposure or misuse. Any questions about storage or disposal can be directed to a pharmacist or clinician.
Pregnancy and breastfeeding require careful consideration of risks and benefits. If pregnancy is planned or suspected, or if breastfeeding is being considered during therapy, a clinician should be consulted to evaluate potential effects on the fetus or infant. The decision to continue treatment will balance maternal health needs with fetal safety considerations.
Contraception and fertility planning may be discussed as part of treatment planning for individuals of childbearing potential. Guidance will be provided by the prescriber, considering the specific clinical situation and treatment goals. Access to information on alternatives and adjustments is available through the healthcare team.
When travelling, maintain a secure supply and carry essential information about the medication. Carrying a copy of the prescription or a letter from the clinician can help with customs or travel considerations, where applicable. Ensure that medication remains in its original packaging and that storage conditions are respected during travel.
Any changes in time zones or daily routine can affect dosing schedules. Plan ahead to align with new schedules and consult the clinician if adjustments are anticipated. If any travel-related concerns arise, such as storage or access to pharmacy services, discuss with a pharmacist before departure.
Daily routines, work schedules, and social activities can be affected by treatment. The goal is to support safety and function while achieving symptom management. Planning ahead and communicating with the care team helps foster consistency in treatment and daily life.
Avoid driving or operating heavy machinery until the effect of the medication on alertness is known and accepted by the clinician. Drowsiness or dizziness may occur, especially when starting therapy or changing the dose. If any concerns arise about functioning or safety, report them to the prescribing clinician promptly.
Alcohol and certain other substances can interact with quetiapine and may intensify sedation or impair coordination. It is advisable to discuss alcohol use with the clinician and to limit or avoid use as recommended. Herbal preparations and over-the-counter medicines can also interact; always check with a pharmacist before starting any new product.
Communication with the care team is encouraged, particularly when new symptoms appear or existing symptoms worsen. Adjustments to the treatment plan can be considered if safety or efficacy concerns arise. The emphasis remains on patient safety, informed decision-making, and ongoing support.
The following questions address common real‑world scenarios. Answers emphasise safety and practical considerations rather than fixed dosing guidance. If uncertainty remains, consult the official patient information leaflet or a healthcare professional. The aim is to support safe and informed use within local practice.
Readers are reminded that access to Seroquel may depend on local rules and clinical assessment. The information provided here is for guidance and does not replace professional medical advice.
Interactions with other medicines can occur. A clinician or pharmacist will review all current medicines, including over-the-counter products and herbal supplements, to assess potential interactions. If multiple medicines are used, timing and monitoring may be adjusted to reduce risk. Always inform the prescribing clinician about new medicines or changes in therapy.
Drowsiness or dizziness may occur, particularly after starting treatment or increasing the dose. It is prudent to assess tolerability before driving or using heavy equipment. If daytime sleepiness persists or worsens, seek medical advice to adjust the plan. Individual responses vary and safety should be the priority.
Improvements may begin gradually, with sleep and energy often responding earlier than other symptoms. Full stabilization can take several weeks. If no meaningful progress is observed after an extended period, a discussion with the prescriber is advised to review the plan and consider adjustments.
The ability to crush or split tablets depends on the specific formulation prescribed. Immediate-release forms are sometimes designed for splitting under certain circumstances, while extended-release forms usually require intact tablets. Consult the pharmacist before altering administration to avoid compromising safety or effectiveness.
Inform the dentist that quetiapine is being taken, especially if dental procedures or anesthesia are planned. Antipsychotic therapy can interact with certain anesthesia regimens or cause oral health effects that require monitoring. The dental team can coordinate with the prescriber if any concerns arise.
Missed doses follow the guidance provided by the prescriber; generally, do not double-dose to catch up. If a dose is missed, take it as soon as remembered if it is not close to the next dose. For significant travel disruptions, contact the clinician or pharmacist to establish a safe adjustment plan that maintains efficacy and safety.
Switching from another antipsychotic or antidepressant is handled by the prescribing clinician. A gradual transition is often recommended to reduce withdrawal effects and adverse reactions. The plan will include timing, tapering, and monitoring for new or worsening symptoms.
Improvements in mood, thinking, and sleep may occur at different times for different people. Some aspects may improve within days, while others require several weeks. Regular follow-up helps determine whether the plan is achieving the desired balance of benefits and tolerability.
Pregnancy and breastfeeding require careful risk-benefit consideration. The decision to continue therapy should be made in consultation with a clinician, weighing maternal health needs against potential effects on the fetus or infant. Alternatives or adjustments may be considered.
abrupt discontinuation is usually discouraged due to the potential for withdrawal effects or symptom relapse. If consideration is given to stopping, a clinician will provide a plan that gradually reduces dose while monitoring safety and symptom control. Always seek professional guidance before stopping.
Many over-the-counter products can interact with antipsychotics. A pharmacist will review potential interactions with analgesics, decongestants, and cold medicines and advise on safe combinations. Use of any non-prescription product should be discussed before starting or combining with quetiapine.
In the event of a fever, severe muscle stiffness, confusion, or unusual changes in heart rhythm or behavior, seek urgent medical help. Such signs may indicate a serious adverse reaction requiring immediate evaluation by a clinician or emergency services.
Long-term use is determined by ongoing assessment of symptom control and tolerability. Regular reviews with the prescriber help ensure that the benefits continue to outweigh the risks. Any concerns about duration or discontinuation should be discussed with a clinician.
Travel plans should include secure, labeled packaging and adherence to storage conditions described on the product label. If there are temperature concerns or storage limitations during travel, consult a pharmacist for practical guidance to maintain medication quality and safety.
In cases where professional support is less readily available, keep a copy of the prescription and a concise summary of the treatment plan. If symptoms worsen or new concerns arise, seek local medical assistance and contact the original prescriber upon return to discuss care options and follow-up needs.
Therapeutic approaches such as psychotherapy, sleep hygiene strategies, regular routines, and social support networks commonly complement pharmacotherapy. Discuss with the care team how these approaches can be integrated with medication to optimise outcomes and overall well-being.
Yes. If adverse effects are bothersome or intolerable, the prescriber may adjust the dose, timing, or formulation, or consider alternative treatments. Any changes should be made under professional supervision, with appropriate monitoring and patient education.
14–21 days. Free from €175.75 .
5–9 days. €26.36
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
